The rapidly evolving UK copyright scene is experiencing a significant shift. While traditional psychedelics like lysergic acid diethylamide and psilocybin remain accessible, a exciting wave of interest is focused on lesser-known compounds. N,N-Dimethyltryptamine, often linked to profound transformative experiences, is attracting significant attenti